SCHEMBL2307564

SCHEMBL2307564

O=C1c2ccccc2C(=O)N1[C@@H]1[C@@H](OCc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 2/20 0.52
▸ SLC6A2 P23975 2/20 0.47
▸ PTPN1 P18031 1/20 0.45
▸ OGA O60502 1/20 0.44
▸ SYNJ2 O15056 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ ALPL P05186 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ ALPI P09923 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ALPG P10696 1/20 0.43
▸ PABPC1 P11940 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ GALK1 P51570 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ CASP6 P55212 1/20 0.43
▸ MCL1 Q07820 1/20 0.43
▸ RIN1 Q13671 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9332545 1.00 LGALS3 (0.52) LGALS3SLC6A2PTPN1OGASYNJ2
SCHEMBL2307547 1.00 LGALS3 (0.52) LGALS3SLC6A2PTPN1OGASYNJ2
SCHEMBL827564 0.88 LGALS3 (0.47) LGALS3PTPN1CYP1A2
SCHEMBL827563 0.88 LGALS3 (0.47) LGALS3PTPN1CYP1A2
SCHEMBL2312267 0.86 LGALS3 (0.50) LGALS3SLC6A2PTPN1LGALS1
SCHEMBL8831095 0.86 LGALS3 (0.44) LGALS3PTPN1OGALGALS1
SCHEMBL8831106 0.86 LGALS3 (0.44) LGALS3PTPN1OGALGALS1
SCHEMBL2313402 0.84 TYMP (0.43) LGALS3SLC6A2
SCHEMBL2313405 0.84 TYMP (0.43) LGALS3SLC6A2
SCHEMBL8398753 0.84 LGALS8 (0.52) LGALS3SLC6A2PTPN1OGALGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1232168-B1 SYNTHETIC LIPID-A ANALOGS AND USES THEREOF ONCOTHYREON INC (US) 2011-08-03 — — EP disclosed
US-6562514-B1 Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries PINNACLE VRB LIMITED (AU) 2003-05-13 — — US disclosed
US-6468688-B2 CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE PINNACLE VRB LIMITED (AU) 2002-10-22 — — US disclosed
EP-1232168-A2 SYNTHETIC LIPID-A ANALOGS AND USES THEREOF BIOMIRA, INC. (CA) 2002-08-21 — — EP disclosed
US-20010028977-A1 Charging, discharging efficiency; vanadium electrolyte JD HOLDING INC. (KY) 2001-10-11 — — US disclosed
WO-2001036433-A2 SYNTHETIC LIPID-A ANALOGS AND USES THEREOF BIOMIRA, INC. (CA) 2001-05-25 — — WO disclosed
US-6143443-A ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE PINNACLE ARB LIMITED (AU) 2000-11-07 — — US disclosed
EP-0729648-A4 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LTD (AU) 1997-01-02 — — EP disclosed
EP-0729648-A1 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1996-09-04 — — EP disclosed
WO-1995012219-A1 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1995-05-04 — — WO disclosed
US-5352811-A To produce homoallylic alcohol, acylation, oxidation of double bond E. I. DU PONT DE NEMOURS AND COMPANY (US) 1994-10-04 — — US disclosed
US-5158941-A Lipid A analog as stimulant for production of interleukin-1 in human monocytes and tumor cell growth inhibitor E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-10-27 — — US disclosed
Send feedback